<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">systhiper</journal-id><journal-title-group><journal-title xml:lang="ru">Системные гипертензии</journal-title><trans-title-group xml:lang="en"><trans-title>Systemic Hypertension</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2075-082X</issn><issn pub-type="epub">2542-2189</issn><publisher><publisher-name>LLC «ИнтерМедсервис»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.38109/2075-082X-2022-2-11-16</article-id><article-id custom-type="elpub" pub-id-type="custom">systhiper-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНАЯ СТАТЬЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLE</subject></subj-group></article-categories><title-group><article-title>Возможности нового метода оценки эффективности работы миокарда у больных с РМЖ при антрациклинсодержащей химиотерапии</article-title><trans-title-group xml:lang="en"><trans-title>Possibilities of a new method for evaluating myocardial work in patients with breast cancer after anthracycline chemotherapy</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0442-4495</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Саидова</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Saidova</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Саидова Марина Абдулатиповна, д.м.н., проф., рук. отд.</p><p>ул. 3-я Черепковская, д. 15 а, г. Москва 121552</p></bio><bio xml:lang="en"><p>Saidova Marina Abdulatipovna, Ph.D.,Head of Ultrasound Diagnostics Department</p><p>3-ia Cherepkovskaia, 15a, Moscow 121552</p></bio><email xlink:type="simple">ani_avalian@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3233-1862</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Авалян</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Avalyan</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Авалян Ани Ашотовна, мл. науч. сотр. отд.</p><p>ул. 3-я Черепковская, д. 15 а, г. Москва 121552</p></bio><bio xml:lang="en"><p>Avalyan Ani Ashotovna, Junior Researcher, Department of Ultrasound Diagnostics</p><p>3-ia Cherepkovskaia, 15a, Moscow 121552</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3253-0669</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ощепкова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Oshchepkova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ощепкова Елена Владимировна, д.м.н., проф., гл. науч. сотр. отд. гипертонии</p><p>ул. 3-я Черепковская, д. 15 а, г. Москва 121552</p></bio><bio xml:lang="en"><p>Oshchepkova Elena Vladimirovna, MD, prof., Chief Scientist, Department of Hypertension</p><p>3-ia Cherepkovskaia, 15a, Moscow 121552</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр кардиологии имени академика Е.И. Чазова» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ye. I. Chazov National Research Medical Center of Cardiology of the Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>15</day><month>11</month><year>2022</year></pub-date><volume>19</volume><issue>2</issue><fpage>11</fpage><lpage>16</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Саидова М.А., Авалян А.А., Ощепкова Е.В., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Саидова М.А., Авалян А.А., Ощепкова Е.В.</copyright-holder><copyright-holder xml:lang="en">Saidova M.A., Avalyan A.A., Oshchepkova E.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.syst-hypertension.ru/jour/article/view/9">https://www.syst-hypertension.ru/jour/article/view/9</self-uri><abstract><sec><title>Цель</title><p>Цель: изучить возможность новой эхокардиографической технологии оценки эффективности работы миокарда в выявлении кардиотоксичности у пациентов с РМЖ в зависимости от уровня АД при антрациклинсодержащей химиотерапии.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В исследование включено 30 пациентов с тройным негативным РМЖ, из них 13 (43,3%) — с АГ. Всем больным проводилась стандартная трансторакальная эхокардиография (ЭхоКГ) с оценкой систолической функции левого желудочка. Для оценки показателя глобальной продольной деформации ЛЖ (GLS) в двумерном режиме применялся метод СТЭ. Также проводилась оценка эффективности работы миокарда.</p></sec><sec><title>Результаты</title><p>Результаты. После химиотерапии у больных РМЖ в среднем по группе показатели ФВ ЛЖ оставались в пределах нормальных значений. Также отмечалось статистически значимое снижение показателя GLS в среднем по группе у пациентов РМЖ. В исследование было показано, что параметры работы миокарда, по-видимому, лучше отражают механическую дисфункцию миокарда ЛЖ по сравнению с показателем GLS, особенно у пациентов с РМЖ и высоким уровнем АД на момент проведения ЭхоКГ.</p></sec><sec><title>Заключение</title><p>Заключение. Первые результаты проведённого исследования показали, что у пациентов РМЖ, у которых на момент исследования регистрировались высокие цифры АД, показатели эффективности работы миокарда лучше отражают механическую дисфункцию миокарда ЛЖ, чем параметр GLS. метод оценки эффективности работы миокарда требует дальнейших исследований и изучения у онкологических пациентов при прохождении курсов химио- и лучевой терапи.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective: to study the possibility of a new echocardiographic technology for assessing the effectiveness of myocardial work in detecting cardiotoxicity in patients with breast cancer, depending on the level of blood pressure during anthracycline chemotherapy.</p></sec><sec><title>Material and methods</title><p>Material and methods: 30 women with triple-negative breast cancer were enrolled, 13 of them (43.3%) had arterial hypertension (AH). All patients underwent standard transthoracic echocardiography with assessment of left ventricular systolic function. The STE method was used to estimate the LV global longitudinal strain (GLS) in a two-dimensional mode. The efficiency of myocardial work was also evaluated.</p></sec><sec><title>Results</title><p>Results. After chemotherapy in patients with breast cancer the LVEF remained within normal values. After chemotherapy in breast cancer patients revealed a statistically significant decrease in GLS and myocardial work parameters. Also it has been shown that myocardial work parameters seem to better reflect the LV mechanical dysfunction compared to the GLS, especially in patients with breast cancer and high blood pressure.</p></sec><sec><title>Conclusion</title><p>Conclusion. The first results of the study showed that in breast cancer patients who had high blood pressure at the time of the study, myocardial work parameters better reflect of the LV mechanical dysfunction than the GLS parameter. A new method for evaluating the effectiveness of myocardial work requires further research and study in cancer patients undergoing chemotherapy and radiation therapy.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>работа миокарда</kwd><kwd>кардиотоксичность</kwd><kwd>химиотерапия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>myocardial work</kwd><kwd>cardiotoxicity</kwd><kwd>chemotherapy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Zamorano J.L., Lancellotti P., Rodriguez Muñoz D. et al. 2016 ESC Position Paper on cancer treatment and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. Eur Heart J. 2016 Sep 21;37(36):2768-2801. https://doi.org/10.1093/eurheartj/ehw211</mixed-citation><mixed-citation xml:lang="en">Zamorano J.L., Lancellotti P., Rodriguez Muñoz D. et al. 2016 ESC Position Paper on cancer treatment and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. Eur Heart J. 2016 Sep 21;37(36):2768-2801. https://doi.org/10.1093/eurheartj/ehw211</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Plana J.C. et al. Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2014 Sep;27(9):911-39. https://doi.org/10.1016/j.echo.2014.07.012</mixed-citation><mixed-citation xml:lang="en">Plana J.C. et al. Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2014 Sep;27(9):911-39. https://doi.org/10.1016/j.echo.2014.07.012</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ciro Santoro1 et al. 2D and 3D strain for detection of subclinicalanthracycline cardiotoxicity in breast cancerpatients: a balance with feasibility. Eur Heart J Cardiovasc Imaging. 2017 May 1;18(8):930-936. https://doi.org/10.1093/ehjci/jex033</mixed-citation><mixed-citation xml:lang="en">Ciro Santoro1 et al. 2D and 3D strain for detection of subclinicalanthracycline cardiotoxicity in breast cancerpatients: a balance with feasibility. Eur Heart J Cardiovasc Imaging. 2017 May 1;18(8):930-936. https://doi.org/10.1093/ehjci/jex033</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">R. Manganaro, S. Marchetta, R. Dulgheru et al. Echocardiographic reference ranges for normal noninvasive myocardial work indices: results from the EACVI NORRE study. European Heart Journal — Cardiovascular Imaging. 2019 May 1;20(5):582-590. https://doi.org/10.1093/ehjci/jey188</mixed-citation><mixed-citation xml:lang="en">R. Manganaro, S. Marchetta, R. Dulgheru et al. Echocardiographic reference ranges for normal noninvasive myocardial work indices: results from the EACVI NORRE study. European Heart Journal — Cardiovascular Imaging. 2019 May 1;20(5):582-590. https://doi.org/10.1093/ehjci/jey188</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Добровольская С.В., Саидова М.А., Сафиуллина А.А., Ускач Т.М., Терещенко С.Н. Оценка эффективности терапии хронической сердечной недостаточности с использованием устройства, модулирующего сердечную сократимость, по данным нового неинвазивного метода анализа работы миокарда. Кардиология. 2021;61(12) стр. 31-40.</mixed-citation><mixed-citation xml:lang="en">Dobrovolskaya S.V., Saidova M.A., Safiullina A.A., Uskach T.M., Tereshchenko S.N. Evaluation of the effectiveness of the chronic heart failure therapy using the device cardiac contractility modulation according to the new non-invasive method of the myocardium work analysis]. Kardiologiia. 2021 Dec 31;61(12):31-40. (in Russ.). https://doi.org/10.18087/cardio.2021.12.n1849</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Dawud Abawi at al. The non invasive assessment of myocardial work by pressure strain analysis: clinical applications. Heart Failure Reviews. 2022 Jul;27(4):1261-1279. https://doi.org/10.1007/s10741-021-10119-4</mixed-citation><mixed-citation xml:lang="en">Dawud Abawi at al. The non invasive assessment of myocardial work by pressure strain analysis: clinical applications. Heart Failure Reviews. 2022 Jul;27(4):1261-1279. https://doi.org/10.1007/s10741-021-10119-4</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Federica Ilardi, Antonello D’Andrea et al. Myocardial Work by Echocardiography: Principles and Applications in Clinical Practice. J. Clin. Med. 2021, 2021 Sep 29;10(19):4521. https://doi.org/10.3390/jcm10194521</mixed-citation><mixed-citation xml:lang="en">Federica Ilardi, Antonello D’Andrea et al. Myocardial Work by Echocardiography: Principles and Applications in Clinical Practice. J. Clin. Med. 2021, 2021 Sep 29;10(19):4521. https://doi.org/10.3390/jcm10194521</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Curigliano G, еt al. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol. 2020 Feb;31(2):171-190. https://doi.org/10.1016/j.annonc.2019.10.023</mixed-citation><mixed-citation xml:lang="en">Curigliano G, еt al. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol. 2020 Feb;31(2):171-190. https://doi.org/10.1016/j.annonc.2019.10.023</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Sawaya H, Sebag IA, Plana JC, et al. Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients. Am J Cardiol. 2011;107(9):1375-80. https://doi.org/10.1016/j.amjcard.2011.01.006</mixed-citation><mixed-citation xml:lang="en">Sawaya H, Sebag IA, Plana JC, et al. Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients. Am J Cardiol. 2011;107(9):1375-80. https://doi.org/10.1016/j.amjcard.2011.01.006</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Boyd A, Stoodley P, Richards D, et al. Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study. PLoS One. 2017 Apr 13;12(4):e0175544. https://doi.org/10.1371/journal.pone.0175544</mixed-citation><mixed-citation xml:lang="en">Boyd A, Stoodley P, Richards D, et al. Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study. PLoS One. 2017 Apr 13;12(4):e0175544. https://doi.org/10.1371/journal.pone.0175544</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Papadopoulos, K.; OzdenTok, Ö.; Mitrousi, K.; Ikonomidis, I. Myocardial Work: Methodology and Clinical Applications. Diagnostics. 2021 Mar 22;11(3):573. https://doi.org/10.3390/diagnostics11030573</mixed-citation><mixed-citation xml:lang="en">Papadopoulos, K.; OzdenTok, Ö.; Mitrousi, K.; Ikonomidis, I. Myocardial Work: Methodology and Clinical Applications. Diagnostics. 2021 Mar 22;11(3):573. https://doi.org/10.3390/diagnostics11030573</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Guan J, Bao W, Xu Y, Yang W, Li M, Xu M, Zhang Y and Zhang M (2021) Assessment of Myocardial Work in Cancer Therapy-Related Cardiac Dysfunction and Analysis of CTRCD Prediction by Echocardiography. Front. Pharmacol. 2021 Nov 11;12:770580. https://doi.org/10.3389/fphar.2021.770580</mixed-citation><mixed-citation xml:lang="en">Guan J, Bao W, Xu Y, Yang W, Li M, Xu M, Zhang Y and Zhang M (2021) Assessment of Myocardial Work in Cancer Therapy-Related Cardiac Dysfunction and Analysis of CTRCD Prediction by Echocardiography. Front. Pharmacol. 2021 Nov 11;12:770580. https://doi.org/10.3389/fphar.2021.770580</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
